论文部分内容阅读
顺氯胺铂〔cis-Dichlorodiammineplatinum(Ⅱ),CDDP〕是第一个证明有抗肿瘤作用的重金属化合物.Rosenberg(1965、1969)首先报告其有抑制细胞分裂和肿瘤生长的作用.1972年临床试用于睾丸和卵巢恶性肿瘤的治疗.近年来进行了大量的研究和临床观察,证明CDDP对多种实验动物和人类肿瘤有良好的治疗作用,对晚期或复发卵巢恶性肿瘤,尤其对多种化疗失败的患者仍有令人鼓舞的疗效,是为卵巢恶性肿瘤有希望的第二线化疗药.
Cis-Dichlorodiammineplatinum (CDDP) was the first heavy metal compound to demonstrate antitumor effects and was first reported by Rosenberg (1965, 1969) as having an inhibitory effect on cell division and tumor growth. In the treatment of testicular and ovarian cancer in recent years a large number of studies and clinical observations that CDDP on a variety of experimental animals and human tumors have a good therapeutic effect on advanced or recurrent ovarian cancer, especially for a variety of chemotherapy failed Of patients still have encouraging results, promising second-line chemotherapy for ovarian cancer.